Partner Institutions

International SAE Consortium (iSAEC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

• Abbott Laboratories, United States of America (USA)
• Amgen Inc., United States of America (USA)
• Cerner Corporation, United States of America (USA)
• Catholic Health Initiatives, United States of America (USA)
• Daiichi Sankyo Co., Ltd., Japan
• Johnson & Johnson, United States of America (USA)
• Merck & Co., Inc., United States of America (USA)
• Novartis International AG, Switzerland
• Roche Palo Alto, LLC, United States of America (USA)
• Sanofi-Aventis, United States of America (USA)
• Wellcome Trust, United Kingdom (UK)
• Broad Institute of MIT and Harvard, United States of America (USA)
• Columbia University in the City of New York (CU), United States of America (USA)
• Duke University, United States of America (USA)
• University of Dundee, United Kingdom (UK)
• U.S. Food and Drug Administration (USFDA), United States of America (USA)
• Illumina, Inc., United States of America (USA)
• Histogenetics LLC, United States of America (USA)
• University of Málaga (UMA), Spain
• Newcastle University, United Kingdom (UK)
• University of California, San Diego (UC San Diego), United States of America (USA)
• U.S. Department of Veterans Affairs, United States of America (USA)
• Drug-Induced Liver Injury Network (DILIN), United States of America (USA)
• Takeda Pharmaceutical Company Limited, Japan
• Pfizer Inc., United States of America (USA)
• IQVIA, United States of America (USA)